Four Anticipatory Medication Domains — SCE Palliative Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Morphine = pain and/or breathlessness; Midazolam = agitation/anxiety; Levomepromazine = nausea and vomiting; Glycopyrronium = respiratory secretions
Explanation lettering: D = shown as A · E = shown as C · C = shown as D · A = shown as E
Option B is correct. UK end‑of‑life anticipatory prescribing guidance (e.g. NHS trust patient information and NICE-aligned practice) clearly maps each drug to a distinct symptom domain: morphine for pain and breathlessness, midazolam for agitation or anxiety, levomepromazine for nausea and vomiting, and glycopyrronium for managing respiratory secretions. These PRN medications are intended for use if the specific symptom arises, not to be given routinely or together. Options A, C, D, and E are incorrect because they either misattribute indications, suggest inappropriate simultaneous administration, or imply interchangeability where none exists.
Reference: Northern Care Alliance: End of Life Care – A guide to anticipatory medications (2025–26); Dudley Group NHS Foundation Trust: Anticipatory medicines (2025–26), https://www.northerncarealliance.nhs.uk/patient-information/patient-leaflets/end-life-care-guide-anticipatory-medications